Back to search

Article

OSTEONECROSIS OF THE JAW (ONJ) IN DIFFERENTIATED THYROID CANCER (DTC): A CASE REPORT AFTER ZOLEDRONIC ACID AND LENVATINIB TREATMENT

2021-04-11

Abstract excerpt

Patients with Differentiated Thyroid Cancer (DTC) and bone metastases (BM) have generally poor prognosis and low survival rate. The management is based on radioiodine therapy, local procedures and systemic therapies, such as kinase inhibitors. The use of antiresorptive drugs (bisphosphonates or denosumab) is essential to prevent skeletal-related events (SREs), and improve quality of life. The concomitant associati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
491449b7-fa1b-5fa3-954a-91e5df704888
DOI
10.32388/irmcki
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
OSTEONECROSIS OF THE JAW (ONJ) IN DIFFERENTIATED THYROID CANCER (DTC): A CASE REPORT AFTER ZOLEDRONIC ACID AND LENVATINIB TREATMENTDOI 10.32388/irmcki
Select a neighboring publication to make it the new centre.